{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T12:53:45Z","timestamp":1768827225696,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Accurate clinical staging is crucial for selection of optimal oncological treatment strategies in non-small cell lung cancer (NSCLC). Although brain MRI, bone scintigraphy and whole-body PET\/CT play important roles in detecting distant metastases, there is a lack of evidence regarding the indication for metastatic staging in early NSCLCs, especially ground-grass nodules (GGNs). Our aim was to determine whether checking for distant metastasis is required in cases of clinical T1N0 GGN.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a retrospective study of initial staging using imaging tests in patients who had undergone complete surgical R0 resection for clinical T1N0 Stage IA NSCLC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 273 patients with cT1N0 GGNs (<jats:italic>n<\/jats:italic>\u2009=\u2009183) or cT1N0 solid tumors (STs, <jats:italic>n<\/jats:italic>\u2009=\u200990) were deemed eligible. No cases of distant metastasis were detected on initial routine imaging evaluations. Among all cT1N0M0 cases, there were 191 incidental findings on various modalities (128 in the GGN). Most frequently detected on brain MRI was cerebral leukoaraiosis, which was found in 98\/273 (35.9%) patients, while cerebral infarction was detected in 12\/273 (4.4%) patients. Treatable neoplasms, including brain meningioma and thyroid, gastric, renal and colon cancers were also detected on PET\/CT (and\/or MRI). Among those, 19 patients were diagnosed with a treatable disease, including other-site cancers curable with surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Extensive staging (MRI, scintigraphy, PET\/CT etc.) for distant metastasis is not required for patients diagnosed with clinical T1N0 GGNs, though various imaging modalities revealed the presence of adventitious diseases with the potential to increase surgical risks, lead to separate management, and worsen patient outcomes, especially in elderly patients. If clinically feasible, it could be considered to complement staging with whole-body procedures including PET\/CT.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40644-024-00714-7","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T14:07:50Z","timestamp":1717423670000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Does clinical T1N0 GGN really require checking for distant metastasis during initial staging for lung cancer?"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4490-7862","authenticated-orcid":false,"given":"Kazuhiro","family":"Imai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyasu","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoko","family":"Konno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinogu","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Kuriyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Demura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzu","family":"Harata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuki","family":"Fujibayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumire","family":"Shibano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyuki","family":"Wakita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushi","family":"Nagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Minamiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,3]]},"reference":[{"key":"714_CR1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1378\/chest.11-2501","volume":"143","author":"B Chang","year":"2013","unstructured":"Chang B, Hwang JH, Choi YH, et al. Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan. Chest. 2013;143:172\u20138. https:\/\/doi.org\/10.1378\/chest.11-2501.","journal-title":"Chest"},{"key":"714_CR2","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.jtcvs.2015.06.024","volume":"150","author":"H Cho","year":"2015","unstructured":"Cho H, Lee HY, Kim J, et al. Pure ground glass nodular adenocarcinomas: are preoperative positron emission tomography\/computed tomography and brain magnetic resonance imaging useful or necessary? J Thorac Cardiovasc Surg. 2015;150:514\u201320. https:\/\/doi.org\/10.1016\/j.jtcvs.2015.06.024.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"suppl4","key":"714_CR3","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/annonc\/mdx222","volume":"28","author":"PE Postmus","year":"2017","unstructured":"Postmus PE, Kerr KM, Oudkerk M, ESMO Guidelines Committee, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(suppl4):iv1\u201321. https:\/\/doi.org\/10.1093\/annonc\/mdx222.","journal-title":"Ann Oncol"},{"key":"714_CR4","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: non-small cell lung cancer [Internet]. Fort Washington: National Comprehensive Cancer Network. 2023. https:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp. Accessed March 10, 2023."},{"key":"714_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.rx.2016.12.001","volume":"59","author":"A Bustos Garc\u00eda de Castro","year":"2017","unstructured":"Bustos Garc\u00eda de Castro A, Ferreir\u00f3s Dom\u00ednguez J, Delgado Bolton R, et al. PET-CT in presurgical lymph node staging in non-small cell lung cancer: the importance of false-negative and false-positive findings. Radiologia. 2017;59:147\u201358. https:\/\/doi.org\/10.1016\/j.rx.2016.12.001.","journal-title":"Radiologia"},{"key":"714_CR6","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/1759-7714.14302","volume":"13","author":"K Kameyama","year":"2022","unstructured":"Kameyama K, Imai K, Ishiyama K, et al. New PET\/CT criterion for predicting lymph node metastasis in resectable advanced (stage IB-III) lung cancer: the standard uptake values ratio of ipsilateral\/contralateral hilar nodes. Thorac Cancer. 2022;13:708\u201315. https:\/\/doi.org\/10.1111\/1759-7714.14302.","journal-title":"Thorac Cancer"},{"issue":"Suppl 3","key":"714_CR7","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1136\/thx.2010.145938","volume":"65","author":"E Lim","year":"2010","unstructured":"Lim E, Baldwin D, Beckles M, et al. Guidelines on the radical management of patients with lung cancer. Thorax. 2010;65(Suppl 3):iii1\u201327. https:\/\/doi.org\/10.1136\/thx.2010.145938.","journal-title":"Thorax"},{"key":"714_CR8","doi-asserted-by":"publisher","first-page":"d2110","DOI":"10.1136\/bmj.d2110","volume":"342","author":"DR Baldwin","year":"2011","unstructured":"Baldwin DR, White B, Schmidt-Hansen M, Champion AR, Melder AM, Guideline Development Group. Diagnosis and treatment of lung cancer: summary of updated NICE guidance. BMJ. 2011;342:d2110. https:\/\/doi.org\/10.1136\/bmj.d2110.","journal-title":"BMJ"},{"issue":"5 Suppl","key":"714_CR9","doi-asserted-by":"publisher","first-page":"eS211","DOI":"10.1378\/chest.12-2355","volume":"143","author":"GA Silvestri","year":"2013","unstructured":"Silvestri GA, Gonzalez AV, Jantz MA, et al. Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):eS211\u2013S50. https:\/\/doi.org\/10.1378\/chest.12-2355.","journal-title":"Chest"},{"key":"714_CR10","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1016\/j.jtho.2016.06.003","volume":"11","author":"J Vernon","year":"2016","unstructured":"Vernon J, Andruszkiewicz N, Schneider L, et al. Comprehensive Clinical staging for Resectable Lung Cancer: clinicopathological correlations and the role of Brain MRI. J Thorac Oncol. 2016;11:1970\u20135. https:\/\/doi.org\/10.1016\/j.jtho.2016.06.003.","journal-title":"J Thorac Oncol"},{"key":"714_CR11","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.chest.2023.02.010","volume":"164","author":"A Manyak","year":"2023","unstructured":"Manyak A, Seaburg L, Bohreer K, Kirtland SH, Hubka M, Gerbino AJ. Invasive procedures Associated with Lung Cancer Screening in Clinical Practice. Chest. 2023;164:544\u201355. https:\/\/doi.org\/10.1016\/j.chest.2023.02.010.","journal-title":"Chest"},{"key":"714_CR12","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1148\/radiol.220234","volume":"303","author":"A Bizzi","year":"2022","unstructured":"Bizzi A, Pascuzzo R. Is brain MRI unnecessary for early-stage Non-small Cell Lung Cancer? Radiology. 2022;303:644\u20135. https:\/\/doi.org\/10.1148\/radiol.220234.","journal-title":"Radiology"},{"key":"714_CR13","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1148\/radiol.212101","volume":"303","author":"JG Nam","year":"2022","unstructured":"Nam JG, Hong H, Choi SH, et al. No prognostic impact of staging Brain MRI in patients with Stage IA Non-small Cell Lung Cancer. Radiology. 2022;303:632\u201343. https:\/\/doi.org\/10.1148\/radiol.212101.","journal-title":"Radiology"},{"key":"714_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1148\/radiol.2020201194","volume":"297","author":"M Kim","year":"2020","unstructured":"Kim M, Suh CH, Lee SM, et al. Diagnostic yield of staging Brain MRI in patients with newly diagnosed Non-small Cell Lung Cancer. Radiology. 2020;297:419\u201327. https:\/\/doi.org\/10.1148\/radiol.2020201194.","journal-title":"Radiology"},{"key":"714_CR15","volume-title":"TNM classification of malignant tumours","year":"2017","unstructured":"Brierley JD, M.K.GospodarowiczC.Wittekind, editor. TNM classification of malignant tumours. 8th ed. New York: Wiley-Blackwell; 2017.","edition":"8"},{"key":"714_CR16","unstructured":"American College of Radiology. ACR Appropriateness Criteria\u00ae [internet]. https:\/\/www.acr.org\/Clinical-Resources\/ACR-Appropriateness-Criteria. Accessed March 10, 2023."},{"key":"714_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.clinimag.2022.10.014","volume":"93","author":"YZ Tang","year":"2023","unstructured":"Tang YZ, Alabousi A. Incidental findings on staging CT for rectal cancer: frequency, clinical significance and outcomes. Clin Imaging. 2023;93:14\u201322. https:\/\/doi.org\/10.1016\/j.clinimag.2022.10.014.","journal-title":"Clin Imaging"},{"key":"714_CR18","doi-asserted-by":"publisher","first-page":"e431","DOI":"10.1016\/j.cllc.2020.06.013","volume":"22","author":"Y Tsutani","year":"2021","unstructured":"Tsutani Y, Nakayama H, Ito H, et al. Long-term outcomes after Sublobar Resection Versus Lobectomy in patients with Clinical Stage IA Lung Adenocarcinoma Meeting the Node-negative Criteria defined by high-resolution computed Tomography and [18F]-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography. Clin Lung Cancer. 2021;22:e431\u20137. https:\/\/doi.org\/10.1016\/j.cllc.2020.06.013.","journal-title":"Clin Lung Cancer"},{"key":"714_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.suronc.2013.04.001","volume":"22","author":"J Li","year":"2013","unstructured":"Li J, Xu W, Kong F, Sun X, Zuo X. Meta-analysis: accuracy of 18FDG PET-CT for distant metastasis staging in lung cancer patients. Surg Oncol. 2013;22:151\u20135. https:\/\/doi.org\/10.1016\/j.suronc.2013.04.001.","journal-title":"Surg Oncol"},{"key":"714_CR20","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1097\/JTO.0b013e3182641bba","volume":"7","author":"M Silva","year":"2012","unstructured":"Silva M, Sverzellati N, Manna C, et al. Long-term surveillance of ground-glass nodules: evidence from the MILD trial. J Thorac Oncol. 2012;7:1541\u20136. https:\/\/doi.org\/10.1097\/JTO.0b013e3182641bba.","journal-title":"J Thorac Oncol"},{"key":"714_CR21","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1007\/s00330-012-2395-4","volume":"22","author":"SM Lee","year":"2012","unstructured":"Lee SM, Park CM, Paeng JC, et al. Accuracy and predictive features of FDG-PET\/CT and CT for diagnosis of lymph node metastasis of T1 non-small-cell lung cancer manifesting as a subsolid nodule. Eur Radiol. 2012;22:1556\u201363. https:\/\/doi.org\/10.1007\/s00330-012-2395-4.","journal-title":"Eur Radiol"},{"key":"714_CR22","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.3978\/j.issn.2072-1439.2015.11.48","volume":"7","author":"L Jiang","year":"2015","unstructured":"Jiang L, Yin W, Peng G, et al. Prognosis and status of lymph node involvement in patients with adenocarcinoma in situ and minimally invasive adenocarcinoma-a systematic literature review and pooled-data analysis. J Thorac Dis. 2015;7:2003\u20139. https:\/\/doi.org\/10.3978\/j.issn.2072-1439.2015.11.48.","journal-title":"J Thorac Dis"},{"issue":"4","key":"714_CR23","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1093\/ejcts\/ezu007","volume":"46","author":"HJ Sim","year":"2014","unstructured":"Sim HJ, Choi SH, Chae EJ, et al. Surgical management of pulmonary adenocarcinoma presenting as a pure ground-glass nodule. Eur J Cardiothorac Surg. 2014;46(4):632\u20136. https:\/\/doi.org\/10.1093\/ejcts\/ezu007. discussion 636.","journal-title":"Eur J Cardiothorac Surg"},{"key":"714_CR24","unstructured":"JLCS Guidelines for Diagnosis and Treatment of Lung Cancer\/Malignant. Pleural Mesothelioma\/Thymic tumor (Japanese only) [internet]. https:\/\/haigan-eng.or.jp\/topics\/guideline.html. Accessed March 10, 2023."},{"key":"714_CR25","unstructured":"ESMO Clinical Practice Guidelines. Lung and Chest Tumours [internet]. https:\/\/www.esmo.org\/guidelines\/guidelines-by-topic\/lung-and-chest-tumours. Accessed March 10, 2023."},{"key":"714_CR26","unstructured":"National Institute for Health and Care Excellence Guidance. Lung cancer: diagnosis and management [internet]. https:\/\/www.nice.org.uk\/guidance\/ng122. Accessed March 10, 2023."},{"key":"714_CR27","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1007\/s00259-004-1492-2","volume":"31","author":"H Schirrmeister","year":"2004","unstructured":"Schirrmeister H, Arslandemir C, Glatting G, et al. Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2004;31:964\u20138. https:\/\/doi.org\/10.1007\/s00259-004-1492-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"714_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/jnci\/dji002","volume":"97","author":"JE Brown","year":"2005","unstructured":"Brown JE, Cook RJ, Major P, et al. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors. J Natl Cancer Inst. 2005;97:59\u201369. https:\/\/doi.org\/10.1093\/jnci\/dji002.","journal-title":"J Natl Cancer Inst"},{"key":"714_CR29","doi-asserted-by":"publisher","unstructured":"Qu X, Huang X, Yan W, Wu L, Dai K. A meta-analysis of 18FDG-PET-CT, 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer. Eur J Radiol. 2012;81:1007\u201315. https:\/\/doi.org\/10.1016\/j.ejrad.2011.01.126.","DOI":"10.1016\/j.ejrad.2011.01.126"},{"key":"714_CR30","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1093\/annonc\/mdl374","volume":"18","author":"BM Fischer","year":"2007","unstructured":"Fischer BM, Mortensen J, Langer SW, et al. A prospective study of PET\/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis. Ann Oncol. 2007;18:338\u201345. https:\/\/doi.org\/10.1093\/annonc\/mdl374.","journal-title":"Ann Oncol"},{"key":"714_CR31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.lungcan.2003.11.008","volume":"44","author":"SK Cheran","year":"2004","unstructured":"Cheran SK, Herndon JE 2nd, Patz EF Jr. Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer. Lung Cancer. 2004;44:317\u201325. https:\/\/doi.org\/10.1016\/j.lungcan.2003.11.008.","journal-title":"Lung Cancer"},{"key":"714_CR32","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.lungcan.2020.08.017","volume":"150","author":"T Berghmans","year":"2020","unstructured":"Berghmans T, Lievens Y, Aapro M, et al. European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): lung cancer. Lung Cancer. 2020;150:221\u201339. https:\/\/doi.org\/10.1016\/j.lungcan.2020.08.017.","journal-title":"Lung Cancer"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-024-00714-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-024-00714-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-024-00714-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T14:15:37Z","timestamp":1717424137000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-024-00714-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,3]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["714"],"URL":"https:\/\/doi.org\/10.1186\/s40644-024-00714-7","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,3]]},"assertion":[{"value":"29 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"IRB Protocol No. 2679 allows collection of images and medical record with consent or waiver of consent when no personalized health information is required, as was the case in this study. Comprehensive written informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}